{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:27:15Z","timestamp":1772598435954,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41390-025-04174-y","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T14:06:09Z","timestamp":1753106769000},"page":"652-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications"],"prefix":"10.1038","volume":"99","author":[{"given":"Janna R.","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang T.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claude","family":"Gingras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Colwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae SM","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the SUCCEED KIDS Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric I.","family":"Benchimol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilan","family":"Dissanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehul","family":"Jariwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizaveta","family":"Limenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosie","family":"Scuccimarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruud H. J.","family":"Verstegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"4174_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamapediatrics.2022.6243","volume":"177","author":"A Watanabe","year":"2023","unstructured":"Watanabe, A. et al. Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis. JAMA Pediatr.177, 384\u2013394 (2023).","journal-title":"JAMA Pediatr."},{"key":"4174_CR2","unstructured":"Government of Canada. Covid-19 Vaccination: Vaccination Coverage, https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/#a5 (2024)."},{"key":"4174_CR3","unstructured":"Government of Canada. in Canadian Immunization Guide (2024)."},{"key":"4174_CR4","doi-asserted-by":"crossref","unstructured":"Panagiotakopoulos, L. Use of Covid-19 Vaccines for Persons Aged\u2265 6 Months: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2024\u20132025. Morbid. Mortal Wkly Rep. 73 (2024).","DOI":"10.15585\/mmwr.mm7337e2"},{"key":"4174_CR5","first-page":"1","volume":"8","author":"A Martini","year":"2022","unstructured":"Martini, A. et al. Juvenile idiopathic arthritis. Nat. Rev. Dis. Prim. 8, 1\u201318 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"4174_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","volume":"77","author":"A Ravelli","year":"2018","unstructured":"Ravelli, A. et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 77, 819\u2013828 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"4174_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/BOR.0000000000000632","volume":"31","author":"G Giancane","year":"2019","unstructured":"Giancane,G. & Ruperto, N.Paediatric Rheumatology International Trials OrganisationTreatment of juvenile idiopathic arthritis: What\u2019s new?Curr. Opin. Rheumatol.31,428\u2013435 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"4174_CR8","first-page":"639","volume":"65","author":"KE Sullivan","year":"2018","unstructured":"Sullivan, K. E. Pathogenesis of pediatric rheumatologic diseases. Pediatr. Clin. 65, 639\u2013655 (2018).","journal-title":"Pediatr. Clin."},{"key":"4174_CR9","doi-asserted-by":"crossref","unstructured":"Sadeghi, P., Pezeshki, P. S. & Rezaei, N. Coronavirus Disease 2019 (COVID-19) in Pediatric Patients with Autoimmune Disorders. Eur. J. Pediatr., 1\u201322 (2023).","DOI":"10.1007\/s00431-023-04958-6"},{"key":"4174_CR10","doi-asserted-by":"publisher","first-page":"919979","DOI":"10.3389\/fimmu.2022.919979","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Liu, Y. & Liu, Y. The flare of rheumatic disease after SARS-CoV-2 Vaccination: A Review. Front. Immunol. 13, 919979 (2022).","journal-title":"Front. Immunol."},{"key":"4174_CR11","doi-asserted-by":"publisher","first-page":"keac140","DOI":"10.1093\/rheumatology\/keac140","volume":"61","author":"\u00d6 Akg\u00fcn","year":"2022","unstructured":"Akg\u00fcn, \u00d6. et al. Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases. Rheumatol. Oxf. Engl. 61, keac140 (2022).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"4174_CR12","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/vaccines10101618","volume":"10","author":"K Kashiwagi","year":"2022","unstructured":"Kashiwagi, K. et al. Impact of Anti-Tnf\u03b1 treatment on the humoral response to the BNT162b2 mRNA COVID-19 vaccine in pediatric inflammatory bowel disease patients. Vaccines 10, 1618 (2022).","journal-title":"Vaccines"},{"key":"4174_CR13","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1136\/gutjnl-2021-326196","volume":"71","author":"ZJ Shire","year":"2022","unstructured":"Shire, Z. J. et al. Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy. Gut 71, 1922\u20131924 (2022).","journal-title":"Gut"},{"key":"4174_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/annrheumdis-2021-221607","volume":"81","author":"D Dimopoulou","year":"2022","unstructured":"Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M. & Maritsi, D. Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with Tnf inhibitors. Ann. Rheum. Dis. 81, 592\u2013593 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"4174_CR15","first-page":"keac352","volume":"62","author":"D Dimopoulou","year":"2022","unstructured":"Dimopoulou, D., Tsolia, M. N., Spyridis, N. & Maritsi, D. N. Immunogenicity 6 months post Covid-19 Mrna vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Rheumatol. Oxf. Engl. 62, keac352 (2022).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"4174_CR16","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/apa.16481","volume":"111","author":"MF Gicchino","year":"2022","unstructured":"Gicchino, M. F., Abbate, F. G., Amodio, A., Giudice, E. M. D. & Olivieri, A. N. Preliminary observations on the immunogenicity and safety of vaccines to prevent Covid-19 in patients with juvenile idiopathic arthritis. Acta Paediatr.111, 2359\u20132361 (2022).","journal-title":"Acta Paediatr."},{"key":"4174_CR17","doi-asserted-by":"publisher","first-page":"keac105","DOI":"10.1093\/rheumatology\/keac105","volume":"61","author":"JG Yeo","year":"2022","unstructured":"Yeo, J. G. et al. Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases. Rheumatol. Oxf. Engl. 61, keac105 (2022).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"4174_CR18","doi-asserted-by":"crossref","unstructured":"Yeo, J. G. et al. COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases. Rheumatology (2023).","DOI":"10.1093\/rheumatology\/kead031"},{"key":"4174_CR19","doi-asserted-by":"publisher","first-page":"keac103","DOI":"10.1093\/rheumatology\/keac103","volume":"61","author":"M Heshin-Bekenstein","year":"2022","unstructured":"Heshin-Bekenstein, M. et al. Safety and Immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications. Rheumatol. Oxf. Engl. 61, keac103 (2022).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"4174_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/vaccines11040819","volume":"11","author":"M Heshin-Bekenstein","year":"2023","unstructured":"Heshin-Bekenstein, M. et al. Safety and immunogenicity following the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents with juvenile-onset autoimmune inflammatory rheumatic diseases: a prospective multicentre study. Vaccines 11, 819 (2023).","journal-title":"Vaccines"},{"key":"4174_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/vaccines10071109","volume":"10","author":"N Cotugno","year":"2022","unstructured":"Cotugno, N. et al. Evaluation of safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in Ibd Pediatric Population with Distinct Immune Suppressive Regimens. Vaccines 10, 1109 (2022).","journal-title":"Vaccines"},{"key":"4174_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15331","volume":"64","author":"K Kamei","year":"2022","unstructured":"Kamei, K. et al. Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agents. Pediatr. Int. 64, e15331 (2022).","journal-title":"Pediatr. Int."},{"key":"4174_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00724-4","volume":"20","author":"C Udaondo","year":"2022","unstructured":"Udaondo, C. et al. Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases. Pediatr. Rheumatol. 20, 64 (2022).","journal-title":"Pediatr. Rheumatol."},{"key":"4174_CR24","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2665-9913(23)00272-2","volume":"6","author":"JS Hanberg","year":"2024","unstructured":"Hanberg, J. S. et al. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial. Lancet Rheumatol. 6, e21\u2013e30 (2024).","journal-title":"Lancet Rheumatol."},{"key":"4174_CR25","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/S2665-9913(22)00330-7","volume":"5","author":"KH Bj\u00f8rlykke","year":"2023","unstructured":"Bj\u00f8rlykke, K. H. et al. Four Sars-Cov-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: A Norwegian Cohort Study. Lancet Rheumatol. 5, e36\u2013e46 (2023).","journal-title":"Lancet Rheumatol."},{"key":"4174_CR26","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. R. Soc. B Biol. Sci. 282, 20143085 (2015).","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"4174_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/jpc.15811","volume":"58","author":"AR Howard-Jones","year":"2022","unstructured":"Howard-Jones, A. R. et al. Covid-19 in Children. II: Pathogenesis, disease spectrum and management. J. Paediatr. Child Health 58, 46\u201353 (2022).","journal-title":"J. Paediatr. Child Health"},{"key":"4174_CR28","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1002\/art.41772","volume":"73","author":"DM Wahezi","year":"2021","unstructured":"Wahezi, D. M. et al. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease during the COVID-19 Pandemic: Version 2. Arthritis Rheumatol. 73, e46\u2013e59 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"4174_CR29","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1136\/annrheumdis-2021-222006","volume":"81","author":"RB Landew\u00e9","year":"2022","unstructured":"Landew\u00e9, R. B. et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: The November 2021 Update. Ann. Rheum. Dis. 81, 1628\u20131639 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"4174_CR30","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1503\/cmaj.230249","volume":"195","author":"TJ Murphy","year":"2023","unstructured":"Murphy, T. J. et al. The evolution of Sars-Cov-2 Seroprevalence in Canada: A Time-Series Study, 2020\u20132023. CMAJ 195, E1030\u2013E1037 (2023).","journal-title":"CMAJ"},{"key":"4174_CR31","doi-asserted-by":"publisher","first-page":"e1380","DOI":"10.1002\/cti2.1380","volume":"11","author":"K Colwill","year":"2022","unstructured":"Colwill, K. et al. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin. Transl. Immunol. 11, e1380 (2022).","journal-title":"Clin. Transl. Immunol."},{"key":"4174_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/rheumatology\/kep352","volume":"49","author":"KL Hyrich","year":"2010","unstructured":"Hyrich, K. L. et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. results from the childhood arthritis prospective study. Rheumatology 49, 116\u2013122 (2010).","journal-title":"Rheumatology"},{"key":"4174_CR33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","volume":"381","author":"DA Salmon","year":"2013","unstructured":"Salmon, D. A. et al. Association between Guillain-Barr\u00e9 Syndrome and Influenza a (H1n1) 2009 Monovalent Inactivated Vaccines in the USA: A Meta-Analysis. Lancet 381, 1461\u20131468 (2013).","journal-title":"Lancet"},{"key":"4174_CR34","unstructured":"Colwill, K. et al. in COVID-19 Immunity Task Force (2023)."},{"key":"4174_CR35","doi-asserted-by":"crossref","unstructured":"Powell, A. A., Dowell, A. C., Moss, P. & Ladhani, S. N. Current State of Covid-19 in Children: 4 Years On. J. Infect., 106134 (2024).","DOI":"10.1016\/j.jinf.2024.106134"},{"key":"4174_CR36","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","volume":"180","author":"JH Anolik","year":"2008","unstructured":"Anolik, J. H. et al. Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits Memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J. Immunol. 180, 688\u2013692 (2008).","journal-title":"J. Immunol."},{"key":"4174_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3542","volume":"13","author":"JJ Kobie","year":"2011","unstructured":"Kobie, J. J. et al. Decreased Influenza-Specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res. Ther. 13, 1\u201312 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"4174_CR38","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","volume":"171","author":"G Cassese","year":"2003","unstructured":"Cassese, G. et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171, 1684\u20131690 (2003).","journal-title":"J. Immunol."},{"key":"4174_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1780-z","volume":"20","author":"J Swart","year":"2018","unstructured":"Swart, J. et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from PharmChild and national registries. Arthritis Res. Ther. 20, 1\u201311 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"4174_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/acr.22961","volume":"69","author":"I Becker","year":"2017","unstructured":"Becker, I. & Horneff, G. Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German biologics in Pediatric Rheumatology Registry. Arthritis Care Res. 69, 552\u2013560 (2017).","journal-title":"Arthritis Care Res."},{"key":"4174_CR41","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/kez096","volume":"58","author":"DN Maritsi","year":"2019","unstructured":"Maritsi, D. N., Kopsidas, I., Vartzelis, G., Spyridis, N. & Tsolia, M. N. Long-term preservation of measles and rubella-specific IgG antibodies in children with enthesitis-related arthritis on anti-tnf\u03b1 treatment: a prospective controlled study. Rheumatology 58, 1686\u20131688 (2019).","journal-title":"Rheumatology"},{"key":"4174_CR42","doi-asserted-by":"crossref","unstructured":"Jansen, M. H. et al. Efficacy, immunogenicity and safety of vaccination in pediatric patients with autoimmune inflammatory rheumatic diseases (PEDAIIRD): A systematic literature review for the 2021 Update of the EULAR\/Pres Recommendations. Front. Pediatr. 10 (2022).","DOI":"10.3389\/fped.2022.910026"},{"key":"4174_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol. Rev. 310, 6\u201326 (2022).","journal-title":"Immunol. Rev."},{"key":"4174_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2024.110859","volume":"135","author":"G Morgan","year":"2025","unstructured":"Morgan, G. et al. Characterizing the Sars-Cov-2 antibody response and associations with patient factors: serological profiling of participants enrolled in the Gencov Study. Clin. Biochem. 135, 110859 (2025).","journal-title":"Clin. Biochem."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04174-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:35:29Z","timestamp":1772548529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04174-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4174"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04174-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent\/assent was obtained from all participants and\/or their substitute decision-makers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}